Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in MLTX — MoonLake Immunotherapeutics

CIK 923093 STAMFORD, CT

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,143,667
-$4,128 QoQ
Shares Held
58,740
-4.6% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#80
of 172 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Derivatives in MLTX

reported options exposure · as of Jun 30, 2026
CallValue
$379,665
CallShares
19,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. MLTX ranks #54 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MLTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $379,665 19,500
2026-06-30 $1,143,667 58,740
2026-03-31 $287,056 15,400
2026-03-31 $1,147,795 61,577
2025-12-31 $155,524 11,800
2025-12-31 $1,364,340 103,516
2025-09-30 $222,270 31,000
2025-06-30 $1,496,900 31,714
2025-03-31 $1,234,299 31,592
2024-09-30 $1,605,372 31,840
2024-06-30 $1,194,796 27,173
2024-03-31 $1,577,774 31,411
2023-12-31 $1,821,000 30,154
2023-09-30 $974,415 17,095
2023-06-30 $690,999 13,549